Journal article · 2023 · Open access

Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy

Yun Chang, Gyuhyung Jin, Weichuan Luo, Qian Luo, Juhyung Jung, Sydney N. Hummel, Sandra E Torregrosa‐Allen, Bennett D. Elzey, Philip Stewart Low, Xiaojun Lance Lian, Xiaoping Bao

Bioactive Materials, 27, 168–180 · Published 5 April 2023 · DOI 10.1016/j.bioactmat.2023.03.018

Open full textCite this paper

In brief

“Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy” is a 2023 journal article by Yun Chang and 10 co-authors, published in Bioactive Materials. OpenAlex counts 37 citations as of 21 November 2026, which puts it in the top 2% of works published in 2023 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Bioactive Materials.

Citations
37
Most cited in
2025 (13)
Field-weighted impact
4.11
References
76
Authors
11

Abstract

Adoptive chimeric antigen receptor (CAR)-engineered natural killer (NK) cells have shown promise in treating various cancers. However, limited immunological memory and access to sufficient numbers of allogenic donor cells have hindered their broader preclinical and clinical applications. Here, we first assess eight different CAR constructs that use an anti-PD-L1 nanobody and/or universal anti-fluorescein (FITC) single-chain variable fragment (scFv) to enhance antigen-specific proliferation and anti-tumor cytotoxicity of NK-92 cells against heterogenous solid tumors. We next genetically engineer human pluripotent stem cells (hPSCs) with optimized CARs and differentiate them into functional dual CAR-NK cells. The tumor microenvironment responsive anti-PD-L1 CAR effectively promoted hPSC-NK cell proliferation and cytotoxicity through antigen-dependent activation of phosphorylated STAT3 (pSTAT3) and pSTAT5 signaling pathways via an intracellular truncated IL-2 receptor β-chain (ΔIL-2Rβ) and STAT3-binding tyrosine-X-X-glutamine (YXXQ) motif. Anti-tumor activities of PD-L1-induced memory-like hPSC-NK cells were further boosted by administering a FITC-folate bi-specific adapter that bridges between a programmable anti-FITC CAR and folate receptor alpha-expressing breast tumor cells. Collectively, our hPSC CAR-NK engineering platform is modular and could constitute a realistic strategy to manufacture off-the-shelf CAR-NK cells with immunological memory-like phenotype for targeted immunotherapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chang, Y., Jin, G., Luo, W., Luo, Q., Jung, J., Hummel, S. N., Torregrosa‐Allen, S. E., Elzey, B. D., Low, P. S., Lian, X. L., & Bao, X. (2023). Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioactive Materials, 27, 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018

MLA 9

Chang, Yun, et al. “Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy.” Bioactive Materials, vol. 27, 2023, pp. 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018.

Chicago

Chang, Yun, Gyuhyung Jin, Weichuan Luo, Qian Luo, Juhyung Jung, Sydney N. Hummel, Sandra E Torregrosa‐Allen, et al. 2023. “Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy.” Bioactive Materials 27: 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018.

Harvard

Chang, Y. et al. (2023) ‘Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy’, Bioactive Materials, 27, pp. 168–180. doi:10.1016/j.bioactmat.2023.03.018.

IEEE

Y. Chang et al., “Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy,” Bioactive Materials, vol. 27, pp. 168–180, 2023, doi: 10.1016/j.bioactmat.2023.03.018.

BibTeX

@article{chang2023engineered,
  title     = {{Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy}},
  author    = {Chang, Yun and Jin, Gyuhyung and Luo, Weichuan and Luo, Qian and Jung, Juhyung and Hummel, Sydney N. and Torregrosa‐Allen, Sandra E and Elzey, Bennett D. and Low, Philip Stewart and Lian, Xiaojun Lance and Bao, Xiaoping},
  journal   = {Bioactive Materials},
  year      = {2023},
  volume    = {27},
  pages     = {168--180},
  doi       = {10.1016/j.bioactmat.2023.03.018},
  url       = {https://doi.org/10.1016/j.bioactmat.2023.03.018}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202388
202488
20251313
202688

Its field-weighted citation impact is 4.11: it has been cited 4.11 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • human pluripotent stem cells
  • PD-L1
  • immunological memory
  • STAT3 signaling
  • STAT5 signaling
  • folate receptor alpha
  • breast cancer
  • adoptive immunotherapy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Chang, Y., Jin, G., Luo, W., Luo, Q., Jung, J., Hummel, S. N., Torregrosa‐Allen, S. E., Elzey, B. D., Low, P. S., Lian, X. L., & Bao, X. (2023). Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioactive Materials, 27, 168–180. https://doi.org/10.1016/j.bioactmat.2023.03.018

How many times has this paper been cited?

37 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Bioactive Materials: sign in and open the full text from this page.

Who wrote this paper?

Yun Chang, Gyuhyung Jin, Weichuan Luo, Qian Luo, Juhyung Jung, Sydney N. Hummel, Sandra E Torregrosa‐Allen, Bennett D. Elzey, Philip Stewart Low, Xiaojun Lance Lian, Xiaoping Bao.

What is the DOI of this paper?

10.1016/j.bioactmat.2023.03.018, permanently at https://doi.org/10.1016/j.bioactmat.2023.03.018. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.